AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Purchase
+$220,000
+63.53%
Shares
Shares Volume: 200,000 Shares
Average Share Price: $1.1
INSIDER
Readnour Robin Shane
Director
reported on Nov 21 2024
traded on Nov 19 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 514,788 |
| PURCHASES/SALES 1Y | 1 / 2 |
| P/S VALUE RATIO | 1.97 |
| AVERAGE PURCHASE VALUE | $220,000 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 3 / 0 |
| PURCHASES/SALES 1Y | 4 / 11 |
| P/S VALUE RATIO | 0.185 |
| AVERAGE PURCHASE VALUE | $463,750 |
| COMPANY PREVIOUS TRADES |